Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2003
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing pre- and post-operative care. As of June 30, 2003, it operated 217 clinics in 34 states. The Company ceased developing new clinic partnerships in 2003; new non-satellite clinics are now wholly owned.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2003 |
Six Months Ended June 30, 2003 |
Six Months Ended June 30, 2002 |
|---|---|---|---|
| Net Revenues | $27,003 | $52,009 | $46,301 |
| Operating Income | $5,018 | $9,093 | $9,767 |
| Net Income | $2,213 | $4,000 | $4,412 |
| Diluted EPS | $0.18 | $0.33 | $0.34 |
| Cash and Equivalents | $12,576 (Balance Sheet) | N/A | |
| Operating Cash Flow | N/A | $9,189 | $10,196 |
| Total Debt (Current + Long Term) | $2,352 | N/A |
Margins (Six Months 2003): Operating margin was approximately 17.5%. Clinic operating costs represented 70% of net revenues.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 12% year-over-year for the six months ended June 30, 2003, driven by a 12% increase in patient visits (550,000 vs. 493,000) and a slight increase in revenue per visit.
- Profit Decline: Despite revenue growth, Net Income declined 9% to $4.0 million. This was primarily due to increased operating costs associated with new clinic openings and higher corporate office expenses.
- Cost Increases: Salaries and related costs rose 15% ($23.6M vs. $20.5M), and rent/supplies increased 23% ($12.0M vs. $9.8M). Approximately 77-82% of these increases were attributed to new clinics.
- Bad Debt Improvement: The provision for doubtful accounts decreased 20% to $756,000, reflecting better collection efforts at mature clinics.
- Liquidity: Cash and cash equivalents increased by $5.0 million to $12.6 million, supported by strong operating cash flows of $9.2 million.
Outlook, Risks, and Management Commentary
- Expansion Strategy: The Company aims to open 47 or more additional clinics in 2003. Management expects initial operating losses from new clinics to negatively impact near-term results, with profitability expected to improve in 2004.
- Medicare Limitation Risk: An annual reimbursement limit of $1,590 per patient for Medicare services is set to take effect September 1, 2003. Management estimates this could reduce 2004 income by up to 10% if not mitigated by secondary insurance or marketing efforts.
- Debt Maturity: A $2.3 million Convertible Subordinated Note is due June 30, 2004. Conversion depends on the stock price reaching $3.33; otherwise, cash repayment will be required. The Company currently holds sufficient cash ($12.6M) to cover this obligation.
- Accounting Changes: The Company adopted several new FASB standards (SFAS 143, 145, 146, FIN 45, 148) in 2003, none of which had a significant impact on financial condition.
Investor Verification Checklist
- Medicare Impact: Verify the actual financial impact of the $1,590 Medicare cap once implemented in Q3 2003.
- New Clinic Performance: Monitor the ramp-up time and profitability of the 23 clinics opened in the first half of 2003.
- Debt Conversion: Track the stock price relative to the $3.33 conversion price of the Series C Note prior to its June 2004 maturity.
- Cost Control: Assess whether clinic operating costs (currently 70% of revenue) stabilize as new clinics mature.
- Share Repurchases: Confirm activity under the new 250,000 share repurchase program authorized in February 2003.